H.R. 7479: Workplace Overdose Reversal Kits to Save Lives Act

This bill, known as the Workplace Overdose Reversal Kits to Save Lives Act, aims to provide guidelines and regulations regarding the use of opioid overdose reversal medications in the workplace. The main components of the bill are as follows:

Non-Mandatory Guidance for Employers

Within 270 days of the bill's enactment, the Secretary of Labor, through the Occupational Safety and Health Administration (OSHA), is required to issue non-mandatory guidance to employers. This guidance will cover:

• How to acquire and maintain opioid overdose reversal medications.
• How to offer voluntary training to employees on the proper use of these medications on an annual basis.

Definition of Employer

The term "employer" is defined as per the Occupational Safety and Health Act of 1970, excluding the United States Postal Service.

Mandatory Regulations for Federal Agencies

In addition to guidance for private employers, the bill mandates that within the same 270-day timeline, the Secretary of Labor must establish regulations requiring each Federal agency to:

• Acquire and maintain opioid overdose reversal medications.
• Offer voluntary training to their employees on the usage of these medications annually.

Definition of Federal Agency

The term "Federal agency" encompasses any agency or instrumentality of the federal government, including the Veterans Health Administration, with specific considerations outlined regarding existing laws.

Overall Purpose

The overarching goal of the bill is to enhance workplace safety by ensuring access to opioid overdose reversal medications and providing training for employees, aiming to reduce the risk and impact of opioid overdoses in workplace settings.

Relevant Companies

None found